Publicacions
-
Sanabria JP, Francesco D'Amico, Cardeñosa E, Ferrer-Forés M, Edo S, Borràs X, McCracken LM, Feliu A, Sanz A and Luciano JV.
Economic evaluation of videoconference group Acceptance and Commitment Therapy and Behavioral Activation Therapy for Depression versus usual care among adults with chronic low back pain plus comorbid depressive symptoms.
JOURNAL OF PAIN . 25(7): 104472-104472.
-
Gallego A, Serrat M, Royuela-Colomer E, Sanabria JP, Borràs X, Esteve M, Grasa M, Rosa A, Rozadilla A, Almirall M, Francesco D'Amico, Dai Y, Rosenbluth MJ, McCracken LM, Navarrete J, Feliu A and Luciano JV.
Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia.
Digital Health . 10: .
-
Sanabria JP, Colomer A, Fernández-Vázquez Ó, Noboa-Rocamora G, Cardona-Ros G, McCracken LM, Montes-Pérez A, Castaño-Asins JR, Edo S, Borràs X, Sanz A, Feliu A and Luciano JV.
A systematic review of cognitive behavioral therapy-based interventions for comorbid chronic pain and clinically relevant psychological distress.
FRONTIERS IN PSYCHOLOGY . 14: 1200685-1200685. Nº de cites: 5
-
Sanabria JP, Colomer A, Borràs X, Castaño-Asins JR, McCracken LM, Montero J, Pérez A, Edo S, Sanz A, Feliu A and Luciano JV.
Efficacy of videoconference group Acceptance and Commitment Therapy (ACT) and Behavioral Activation Therapy for Depression (BATD) for chronic low back pain (CLBP) plus comorbid depressive symptoms: A randomized controlled trial (IMPACT study).
JOURNAL OF PAIN . 24(8): 1522-1540. Nº de cites: 13
-
Serrat M, Ferrés S, Auer W, Almirall M, Lluch E, D'Amico F, Maes M, Lorente S, Navarrete J, Montero J, Neblett R, Nijs J, Borràs X, Luciano JV and Feliu A.
Effectiveness, cost-utility and physiological underpinnings of the FIBROWALK multicomponent therapy in online and outdoor format in individuals with fibromyalgia: Study protocol of a randomized, controlled trial (On&Out study).
FRONTIERS IN PHYSIOLOGY . 13: 1046613-1046613. Nº de cites: 2
-
Sanabria JP, Colomer A, Carmona-Cervelló M, Feliu A, Borràs X, Grasa M, Esteve M, Maes M, Edo S, Sanz A and Luciano JV.
Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain: A systematic review.
FRONTIERS IN IMMUNOLOGY . 13: 945513-945513. Nº de cites: 6
-
Colomer A, Sanabria JP, Hernández-Negrín H, Borràs X, Suso-Ribera C, García-Palacios A, Muchart-Lopez J, Munuera-del Cerro JL, Francesco D'Amico, Maes M, Younger JW, Feliu A, Rozadilla A and Luciano JV.
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
BMJ Open . 12(1): . Nº de cites: 7
-
Sanabria JP, Montero-Marin J, Feliu A, Gasión V, Navarro-Gil M, Morillo-Sarto H, Colomer A, Borràs X, Tops M, Luciano JV and García-Campayo J.
Mindfulness-Based Program Plus Amygdala and Insula Retraining (MAIR) for the Treatment of Women with Fibromyalgia: A Pilot Randomized Controlled Trial.
Journal of Clinical Medicine . 9(10): . Nº de cites: 14
-
Sanabria JP, Forero CG, Cristobal P, Suso-Ribera C, García-Palacios A, Colomer A, Pérez A, Andrés L, McCracken LM, Francesco D'Amico, Pere Estivill Rodriguez, Bernat Carreras Marcos, Montes-Pérez A, Comps-Vicente O, Esteve M, Grasa M, Rosa A, Cuesta Vargas A, Maes M, Borràs X, Edo S, Sanz A, Feliu A, Castaño-Asins JR and Luciano JV.
Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study).
BMJ Open . 10(7): . Nº de cites: 10